In conclusion, we demonstrate that common noncoding regulatory variants at the previously identified 3p21.31 risk locus and rare pathogenic coding variants in CCR5 can contribute to severe clinical manifestations of COVID-19 by affecting CCR5 functions. This evidence concerns the gene CCR5 and COVID-19.